Subtopic Deep Dive
Intensive Insulin Therapy in Surgical ICU Patients
Research Guide
What is Intensive Insulin Therapy in Surgical ICU Patients?
Intensive insulin therapy in surgical ICU patients uses insulin infusions to maintain strict blood glucose targets, typically 80-110 mg/dL, to reduce morbidity and mortality post-surgery.
Van den Berghe et al. (2001) first demonstrated in a randomized trial that targeting glucose ≤110 mg/dL in surgical ICU patients reduced mortality by 34% and morbidity including infections (9951 citations). The NICE-SUGAR trial (2009) later showed intensive control (81-108 mg/dL) increased mortality compared to ≤180 mg/dL (5007 citations). Subsequent guidelines from ADA Standards (2009-2022) recommend moderate targets of 140-180 mg/dL to balance benefits and hypoglycemia risks.
Why It Matters
Intensive insulin therapy protocols in surgical ICUs lower perioperative infections, accelerate wound healing, and shorten hospital stays, reducing healthcare costs in high-volume centers. Van den Berghe et al. (2001) reported 46% fewer kidney injuries and faster discharges. NICE-SUGAR investigators (2009) highlighted risks of tight control, influencing global guidelines like Moghissi et al. (2009) consensus for safer 140-180 mg/dL targets, adopted in millions of procedures annually.
Key Research Challenges
Hypoglycemia Risk
Tight glucose targets increase severe hypoglycemia episodes, linked to higher mortality in NICE-SUGAR (2009). Balancing control without lows remains difficult in fluctuating surgical stress states. Van den Berghe et al. (2006) noted similar issues in prolonged medical ICU stays.
Optimal Glucose Target
Conflicting trials debate 80-110 vs. 140-180 mg/dL; Van den Berghe (2001) favored tight control, but NICE-SUGAR (2009) showed harm. No consensus exists for surgical subgroups. ADA Standards (2012, 2021) recommend moderation pending further RCTs.
Infusion Algorithm Variability
Heterogeneous insulin protocols lead to inconsistent glucose control across ICUs. Van den Berghe trials used nurse-driven algorithms, but scalability varies. Moghissi et al. (2009) stress standardized systems for safety.
Essential Papers
Intensive Insulin Therapy in Critically Ill Patients
Greet Van den Berghe, Pieter Wouters, Frank Weekers et al. · 2001 · New England Journal of Medicine · 10.0K citations
Intensive insulin therapy to maintain blood glucose at or below 110 mg per deciliter reduces morbidity and mortality among critically ill patients in the surgical intensive care unit.
Intensive versus Conventional Glucose Control in Critically Ill Patients
Nice-Sugar Study Investigators · 2009 · New England Journal of Medicine · 5.0K citations
In this large, international, randomized trial, we found that intensive glucose control increased mortality among adults in the ICU: a blood glucose target of 180 mg or less per deciliter resulted ...
2. Classification and Diagnosis of Diabetes:<i>Standards of Medical Care in Diabetes—2022</i>
Unknown · 2021 · Diabetes Care · 4.6K citations
The American Diabetes Association (ADA) “Standards of Medical Care in Diabetes” includes the ADA’s current clinical practice recommendations and is intended to provide the components of diabetes ca...
Standards of Medical Care in Diabetes—2013
Unknown · 2012 · Diabetes Care · 4.4K citations
AClear evidence from well-conducted, generalizable RCTs that are adequately powered, including: c Evidence from a well-conducted multicenter trial c Evidence from a meta-analysis that incorporated ...
Intensive Insulin Therapy in the Medical ICU
Greet Van den Berghe, Alexander Wilmer, Greet Hermans et al. · 2006 · New England Journal of Medicine · 3.6K citations
Intensive insulin therapy significantly reduced morbidity but not mortality among all patients in the medical ICU. Although the risk of subsequent death and disease was reduced in patients treated ...
Standards of Medical Care in Diabetes—2010
Unknown · 2009 · Diabetes Care · 3.4K citations
Standards of Medical Care in Diabetes—2011
Unknown · 2010 · Diabetes Care · 2.9K citations
A. Classification of diabetes B. Diagnosis of diabetes C. Categories of increased risk for diabetes (prediabetes) II
Reading Guide
Foundational Papers
Start with Van den Berghe et al. (2001) for surgical ICU benefits (9951 citations), then NICE-SUGAR (2009) for risks (5007 citations), followed by Van den Berghe (2006) for medical extensions.
Recent Advances
ADA Standards 2022 (4561 citations) and 2013 (4414 citations) for current moderate targets; Moghissi et al. (2009) consensus on inpatient control.
Core Methods
Continuous insulin infusions with point-of-care glucose monitoring, computer-guided algorithms, and protocolized targets of 140-180 mg/dL per guidelines.
How PapersFlow Helps You Research Intensive Insulin Therapy in Surgical ICU Patients
Discover & Search
Research Agent uses searchPapers and citationGraph on 'Van den Berghe 2001' to map 9951 citing papers, revealing surgical ICU extensions; exaSearch uncovers protocol variants, while findSimilarPapers links NICE-SUGAR (2009) to 5007 related trials.
Analyze & Verify
Analysis Agent applies readPaperContent to extract glucose targets from Van den Berghe (2001), verifies mortality claims via verifyResponse (CoVe) against NICE-SUGAR (2009), and runs GRADE grading for RCT evidence quality; runPythonAnalysis computes meta-analysis odds ratios from trial data using pandas.
Synthesize & Write
Synthesis Agent detects gaps like long-term surgical outcomes via gap detection and flags contradictions between Van den Berghe (2001) and NICE-SUGAR (2009); Writing Agent uses latexEditText, latexSyncCitations for guideline tables, and latexCompile for protocol flowcharts with exportMermaid.
Use Cases
"Meta-analyze hypoglycemia rates from surgical ICU insulin trials"
Research Agent → searchPapers('intensive insulin surgical ICU') → Analysis Agent → runPythonAnalysis(pandas odds ratio calc on extracted data) → CSV export of forest plot stats.
"Draft LaTeX review on glucose targets post-cardiac surgery"
Synthesis Agent → gap detection on Van den Berghe/NICE-SUGAR → Writing Agent → latexEditText(draft sections) → latexSyncCitations(10 papers) → latexCompile(PDF with target comparison table).
"Find code for insulin infusion calculators from papers"
Research Agent → paperExtractUrls('insulin algorithm ICU') → paperFindGithubRepo → githubRepoInspect → runPythonAnalysis(test infusion model sandbox).
Automated Workflows
Deep Research workflow conducts systematic review of 50+ citing papers to Van den Berghe (2001), generating structured report on surgical outcomes with GRADE scores. DeepScan applies 7-step CoVe chain to verify NICE-SUGAR (2009) mortality claims against ADA guidelines. Theorizer hypothesizes optimal targets from trial contradictions, exporting Mermaid decision trees.
Frequently Asked Questions
What is intensive insulin therapy in surgical ICU patients?
It involves continuous insulin infusions targeting blood glucose 80-110 mg/dL to minimize perioperative complications, as pioneered by Van den Berghe et al. (2001).
What methods are used for glycemic control?
Nurse-adjusted infusions with hourly glucose checks and algorithms; Van den Berghe (2001) used ≤110 mg/dL, while NICE-SUGAR (2009) tested 81-108 vs. ≤180 mg/dL.
What are the key papers?
Van den Berghe et al. (2001, 9951 citations) showed benefits; NICE-SUGAR (2009, 5007 citations) showed risks; Van den Berghe (2006, 3630 citations) extended to medical ICUs.
What open problems remain?
Optimal targets for surgical subgroups, hypoglycemia prevention, and scalable algorithms; post-NICE-SUGAR trials lack consensus per Moghissi et al. (2009).
Research Hyperglycemia and glycemic control in critically ill and hospitalized patients with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Intensive Insulin Therapy in Surgical ICU Patients with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers